FR 
EN 
ZH 
RU 
DE 
ES 
KO 
PT 
TH 
AR 
IT 
VI 
NL 
CAS No.:1197-18-8
Autres Noms:acide Tranexamique
MF:C8H15NO2, C8H15NO2
EINECS No.:214-818-2Synonyms: TIMTEC-BB SBB006715; TRANS-4-AMINOMETHYL-1-CYCLOHEXANECARBOXYLIC ACID; trans-4-aminomethylcyclohexane-1-carboxylate
what is of Tranexamic Acid Powder with cas 1197-18-8?
Tranexamic acid is a synthetic derivative of lysine. It is a commonly used hemostatic agent in clinical practice. It plays a hemostatic effect by inhibiting the dissolution of fibrin. Trantranic acid can strongly adsorb Lysine-binding sites of fibrinogen affinity sites on plasminase and plasminogen, and inhibit the binding of plasminogen and fibrin, and thus strongly inhibit the decomposition of fibrin caused by plasminogen. In addition, the antifibrinolytic effect of tranatemic acid was more obvious in the presence of antifibrinolytic enzymes such as macroglobulin in serum
Spécification
| Les éléments de Test | Standard as per USP30 |
|
Description |
1.White crystalline powder,Odorless and has a bitter taste |
| 2.Freely soluble in water and glacial Acetic acid; very slightly soluble in ethanol; practically insoluble in Ether | |
| 3.dissolves in sodium hydroxide TS | |
|
Identification |
1.Nimhydrin reaction produces a Deep purple colour |
| 2.the dried precipitate formed with
p-toluenesulfonic acid melts between 265.0℃-266.0℃ |
|
| La clarté de solution | Clear and colourless |
| Chlorure de | ≤0.014% |
| Lourd metals | ≤10ppm |
| L'Arsenic | ≤22ppm |
| Readily carbonizable substances | NO colour develops |
| Cis-Isomer | ≤0.8% |
| La perte de sur séchage | ≤0,5% de |
| Residue sur allumage | ≤0.10% |
| Dosage | ≥99.0%of C₈H1sNo₂ (dried) |
L'utilisation de la
Tranexamic acid is a synthetic derivative of lysine, which is an antifibrinolytic drug and has hemostatic properties
Hemostatic agents have significant effect on traumatic bleeding, and prophylactic medication before surgery can reduce surgical bleeding
Emballage
25kgs/tambour, 9tons/20'container
25kgs/sac, 20tons/20'container
